Literature DB >> 26072052

Efficacy of dual-hormone artificial pancreas to alleviate the carbohydrate-counting burden of type 1 diabetes: A randomized crossover trial.

V Gingras1, R Rabasa-Lhoret2, V Messier3, M Ladouceur4, L Legault5, A Haidar6.   

Abstract

AIM: Carbohydrate-counting is a complex task for many patients with type 1 diabetes. This study examined whether an artificial pancreas, delivering insulin and glucagon based on glucose sensor readings, could alleviate the burden of carbohydrate-counting without degrading glucose control.
METHODS: Twelve adults were recruited into a randomized, three-way, crossover trial (ClinicalTrials.gov identifier No. NCT01930097). Participants were admitted on three occasions from 7AM to 9PM and consumed a low-carbohydrate breakfast (women: 30g; men: 50g), a medium-carbohydrate dinner (women: 50g; men: 70g) and a high-carbohydrate lunch (women: 90g; men: 120g). At each visit, glucose levels were randomly regulated by: (1) conventional pump therapy; (2) an artificial pancreas (AP) accompanied by prandial boluses, matching the meal's carbohydrate content based on insulin-to-carbohydrate ratios (AP with carbohydrate-counting); or (3) an AP accompanied by prandial boluses based on qualitative categorization (regular or large) of meal size (AP without carbohydrate-counting).
RESULTS: The AP without carbohydrate-counting achieved similar incremental AUC values compared with carbohydrate-counting after the low- (P=0.54) and medium- (P=0.38) carbohydrate meals, but yielded higher post-meal excursions after the high-carbohydrate meal (P=0.004). The AP with and without carbohydrate-counting yielded similar mean glucose levels (8.2±2.1mmol/L vs. 8.4±1.7mmol/L; P=0.52), and both strategies resulted in lower mean glucose compared with conventional pump therapy (9.6±2.0mmol/L; P=0.02 and P=0.03, respectively).
CONCLUSION: The AP with qualitative categorization of meal size could alleviate the burden of carbohydrate-counting without compromising glucose control, although more categories of meal sizes are probably needed to effectively control higher-carbohydrate meals.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Artificial pancreas; Carbohydrate-counting; Closed-loop hormonal delivery systems; Continuous glucose monitoring; Type 1 diabetes

Mesh:

Substances:

Year:  2015        PMID: 26072052     DOI: 10.1016/j.diabet.2015.05.001

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  16 in total

Review 1.  Role of Glucagon in Automated Insulin Delivery.

Authors:  Leah M Wilson; Peter G Jacobs; Jessica R Castle
Journal:  Endocrinol Metab Clin North Am       Date:  2019-12-10       Impact factor: 4.741

2.  Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.

Authors:  Gregory P Forlenza; Faye M Cameron; Trang T Ly; David Lam; Daniel P Howsmon; Nihat Baysal; Georgia Kulina; Laurel Messer; Paula Clinton; Camilla Levister; Stephen D Patek; Carol J Levy; R Paul Wadwa; David M Maahs; B Wayne Bequette; Bruce A Buckingham
Journal:  Diabetes Technol Ther       Date:  2018-04-16       Impact factor: 6.118

3.  A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm.

Authors:  Laurel H Messer; Cari Berget; Gregory P Forlenza
Journal:  Diabetes Technol Ther       Date:  2019-05-29       Impact factor: 6.118

4.  Impact of erroneous meal insulin bolus with dual-hormone artificial pancreas using a simplified bolus strategy - A randomized controlled trial.

Authors:  Véronique Gingras; Mohamed Raef Smaoui; Charlotte Cameli; Virginie Messier; Martin Ladouceur; Laurent Legault; Rémi Rabasa-Lhoret
Journal:  Sci Rep       Date:  2018-02-08       Impact factor: 4.379

Review 5.  Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.

Authors:  David Rodbard
Journal:  Diabetes Technol Ther       Date:  2017-06       Impact factor: 6.118

6.  Artificial Pancreas: Evaluating the ARG Algorithm Without Meal Announcement.

Authors:  Emilia Fushimi; Patricio Colmegna; Hernán De Battista; Fabricio Garelli; Ricardo Sánchez-Peña
Journal:  J Diabetes Sci Technol       Date:  2019-07-24

Review 7.  A critical review and analysis of ethical issues associated with the artificial pancreas.

Authors:  A Quintal; V Messier; R Rabasa-Lhoret; E Racine
Journal:  Diabetes Metab       Date:  2018-04-25       Impact factor: 6.041

Review 8.  Progress in understanding type 1 diabetes through its genetic overlap with other autoimmune diseases.

Authors:  Jeffrey D Roizen; Jonathan P Bradfield; Hakon Hakonarson
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

Review 9.  The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes.

Authors:  Véronique Gingras; Nadine Taleb; Amélie Roy-Fleming; Laurent Legault; Rémi Rabasa-Lhoret
Journal:  Diabetes Obes Metab       Date:  2017-08-10       Impact factor: 6.577

10.  Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin Boluses.

Authors:  Ricardo Sánchez-Peña; Patricio Colmegna; Fabricio Garelli; Hernán De Battista; Demián García-Violini; Marcela Moscoso-Vásquez; Nicolás Rosales; Emilia Fushimi; Enrique Campos-Náñez; Marc Breton; Valeria Beruto; Paula Scibona; Cintia Rodriguez; Javier Giunta; Ventura Simonovich; Waldo H Belloso; Daniel Cherñavvsky; Luis Grosembacher
Journal:  J Diabetes Sci Technol       Date:  2018-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.